| |
| |
|
| Insider
Information: |
Cartt Stephen Lahue |
| Relationship: |
|
| City: |
Union City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
447,908 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$419,379 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
447,908 |
|
|
| Total
Value |
$419,379 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Chief Operating Officer |
2014-08-14 |
0 |
2007-12-10 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2015-08-18 |
155,125 |
|
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
|
2017-03-30 |
292,783 |
2016-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2016-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2016-06-10 |
4 |
B |
$2.93 |
$146,530 |
D/D |
50,000 |
250,000 |
2.81 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2016-06-30 |
4 |
B |
$2.40 |
$23,977 |
D/D |
10,000 |
260,000 |
2.81 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2017-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
32,783 |
292,783 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2014-11-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,125 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2015-08-14 |
4 |
B |
$2.65 |
$48,756 |
D/D |
18,400 |
98,525 |
2.39 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2015-08-17 |
4 |
B |
$2.83 |
$111,478 |
D/D |
39,400 |
137,925 |
2.39 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2015-08-18 |
4 |
B |
$2.90 |
$49,832 |
D/D |
17,200 |
155,125 |
2.39 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Executive Vice President |
• – – |
2005-10-31 |
4 |
B |
$0.62 |
$22,569 |
I/I |
35,400 |
65,129 |
1.99 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Executive Vice President |
• – – |
2005-11-30 |
4 |
A |
$0.52 |
$5,326 |
D/D |
10,271 |
75,400 |
|
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Executive Vice President |
• – – |
2006-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
56,805 |
132,205 |
|
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Executive Vice President |
• – – |
2007-12-10 |
4 |
S |
$6.00 |
$212,400 |
I/I |
(35,400) |
0 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Executive Vice President |
• – – |
2007-12-10 |
4 |
S |
$6.01 |
$85,354 |
D/D |
(14,202) |
632,186 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Executive Vice President |
• – – |
2007-12-12 |
4 |
S |
$5.75 |
$431,250 |
D/D |
(75,000) |
557,186 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2008-03-18 |
4 |
S |
$4.01 |
$401,000 |
D/D |
(100,000) |
62,640 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
EXEC. VP CORPORATE DEVELOPMENT |
• – – |
2008-05-30 |
4 |
S |
$5.30 |
$530,000 |
D/D |
(100,000) |
84,582 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
EXEC. VP CORPORATE DEVELOPMENT |
• – – |
2008-05-30 |
4 |
OE |
$0.46 |
$46,000 |
D/D |
100,000 |
184,582 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2008-06-09 |
4 |
D |
$5.18 |
$26,294 |
D/D |
(5,076) |
79,506 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2008-12-10 |
4 |
S |
$9.50 |
$950,000 |
D/D |
(100,000) |
79,908 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2008-12-10 |
4 |
OE |
$0.46 |
$46,000 |
D/D |
100,000 |
179,908 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2009-06-09 |
4 |
D |
$4.70 |
$23,857 |
D/D |
(5,076) |
77,756 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2009-08-03 |
4 |
OE |
$0.46 |
$69,000 |
D/D |
150,000 |
227,756 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2009-08-03 |
4 |
S |
$6.04 |
$908,000 |
D/D |
(150,000) |
77,756 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2009-08-04 |
4 |
S |
$6.12 |
$612,000 |
D/D |
(100,000) |
77,756 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2009-08-04 |
4 |
OE |
$0.46 |
$46,000 |
D/D |
100,000 |
177,756 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
